CALA Insider Trading Activity and SEC Form 4 Filings
CALA insider trading summary
No open-market insider purchases or sales of Calithera Biosciences, Inc. (CALA) have been reported on SEC Form 4 in the past 12 months.
Latest CALA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 27, 2023 | Deepika Pakianathan | Director | Sell | $452 (1,172 @ $0.39) |
| Jan 27, 2023 | Deepika Pakianathan | Director | Sell | $46K (120,161 @ $0.39) |
| Nov 11, 2021 | Keith Orford | Director | Sell | $42K (48,190 @ $0.88) |
| Nov 10, 2021 | Christopher Molineaux | Sr. VP, Development | Buy | $85K (100,000 @ $0.85) |
| Nov 10, 2021 | Keith Orford | Director | Sell | $26K (30,000 @ $0.86) |
| Nov 10, 2021 | Susan Molineaux | President & CEO | Buy | $85K (100,000 @ $0.85) |
| Nov 10, 2021 | Jonathan G Drachman | Director | Buy | $172K (200,000 @ $0.86) |
| Nov 9, 2021 | Keith Orford | Director | Sell | $44K (51,810 @ $0.84) |
| Dec 16, 2020 | Keith Orford | Chief Medical Officer | Sell | $15K (2,447 @ $6.00) |
| May 21, 2020 | BVF Partners OS Ltd. | Insider | Sell | $1.2M (192,250 @ $6.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.